EAACI Congress 2025 Back

13 - 16 June 2025 Glasgow, United Kingdom

Sophia Karagiannis

United Kingdom

Sophia Karagiannis

B cell immunologist with academic and biotechnology experience, focused on developing antibodies and antibody-drug conjugates for cancer therapy and dissecting humoral immunity in tumours. First to design and translate IgE therapies for cancer to clinical testing and founder of Epsilogen Ltd.

Sessions

Friday 13 Jun
16:45 - 18:15
OAS06
From Basic Immunology to translational applications Oral Abstract Sessions Carron 2
Saturday 14 Jun
16:45 - 18:15
SY18
Th2 immune responses and clinical outcomes Symposium Hall 1